Trulieve CEO ‘Not Concerned’ by DEA’s Middleman Role in Schedule III Order

April 24, 2026

Kim Rivers dives into the feds’ impending access to her company’s facilities and other treaty obligations, as well as 280E taxes, product development and scientific research.